-->
Update - 22 January 2022
Our Innovation Centres remain operational and accessible, and provide a safe environment for our staff and customers. We continue to assess the risk of COVID-19 alongside the latest guidance from government. In the meantime our Innovation Centre remains COVID-19 Secure and fully open for business. Our detailed risk assessment can be found here.
Optellum wins NHS funding for its AI decision support to detect early-stage lung cancer this week.
One of our Oxford Centre for Innovation-based companies, Optellum launches the world’s first AI decision support for early lung cancer detection.
Update – 11 August 2022
Our Innovation Centres remain operational and accessible, and provide a safe environment for our staff and customers. We continue to assess the risk of COVID-19 alongside the latest guidance from government. In the meantime our Innovation Centre remains COVID-19 Secure and fully open for business. Our detailed risk assessment can be found here.
